Health Insurance Innovations (NASDAQ:HIIQ) has received an average recommendation of “Buy” from the twelve research firms that are covering the firm, MarketBeat reports. Eleven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $42.62.
Several research firms recently commented on HIIQ. Canaccord Genuity reissued a “buy” rating and set a $55.00 price target (up from $39.00) on shares of Health Insurance Innovations in a research report on Friday, March 2nd. BidaskClub lowered Health Insurance Innovations from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. UBS raised Health Insurance Innovations from a “neutral” rating to an “outperform” rating and set a $38.00 price target on the stock in a research report on Thursday, March 1st. Craig Hallum reissued a “buy” rating and set a $45.00 price target (up from $38.00) on shares of Health Insurance Innovations in a research report on Thursday, March 1st. Finally, Lake Street Capital boosted their price target on Health Insurance Innovations to $50.00 and gave the stock a “buy” rating in a research report on Thursday, March 1st.
In other Health Insurance Innovations news, CTO Sheldon Wang sold 5,000 shares of Health Insurance Innovations stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $31.80, for a total transaction of $159,000.00. Following the sale, the chief technology officer now directly owns 74,001 shares in the company, valued at approximately $2,353,231.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 77,464 shares of company stock worth $2,153,800 over the last three months. 30.00% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the business. Lyon Street Capital LLC increased its holdings in Health Insurance Innovations by 55.2% during the 4th quarter. Lyon Street Capital LLC now owns 1,453,484 shares of the financial services provider’s stock worth $36,264,000 after purchasing an additional 516,737 shares during the last quarter. BlackRock Inc. increased its holdings in Health Insurance Innovations by 0.5% during the 4th quarter. BlackRock Inc. now owns 823,596 shares of the financial services provider’s stock worth $20,548,000 after purchasing an additional 4,154 shares during the last quarter. CAS Investment Partners LLC purchased a new stake in Health Insurance Innovations during the 4th quarter worth approximately $18,717,000. Arrowstreet Capital Limited Partnership increased its holdings in Health Insurance Innovations by 131.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 668,208 shares of the financial services provider’s stock worth $16,672,000 after purchasing an additional 379,308 shares during the last quarter. Finally, B. Riley Financial Inc. increased its holdings in Health Insurance Innovations by 62.0% during the 3rd quarter. B. Riley Financial Inc. now owns 405,000 shares of the financial services provider’s stock worth $5,873,000 after purchasing an additional 155,000 shares during the last quarter. Institutional investors own 79.22% of the company’s stock.
HIIQ stock opened at $31.05 on Wednesday. The firm has a market capitalization of $497.99, a PE ratio of 20.29 and a beta of 0.42. Health Insurance Innovations has a 52 week low of $12.65 and a 52 week high of $37.38.
Health Insurance Innovations (NASDAQ:HIIQ) last released its quarterly earnings data on Wednesday, February 28th. The financial services provider reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.03. The business had revenue of $69.50 million for the quarter, compared to analyst estimates of $59.93 million. Health Insurance Innovations had a return on equity of 21.27% and a net margin of 7.14%. Health Insurance Innovations’s quarterly revenue was up 35.2% compared to the same quarter last year. research analysts predict that Health Insurance Innovations will post 1.95 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This article was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.thelincolnianonline.com/2018/03/21/health-insurance-innovations-hiiq-given-consensus-recommendation-of-buy-by-brokerages.html.
About Health Insurance Innovations
Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.